These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4137763)

  • 1. Letter: Cyclophosphamide and neoplasia.
    Wood L
    Lancet; 1974 Oct; 2(7885):898-9. PubMed ID: 4137763
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant mixed mullerian tumor of the cervix following cyclophosphamide therapy for nephrotic syndrome.
    Bashour BN; Mancer K; Rance CP
    J Pediatr; 1973 Feb; 82(2):292-3. PubMed ID: 4346219
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclophosphamide in minimal-change nephrotic syndrome.
    Uldall PR; Feest TG; Morley AR; Tomlinson BE; Kerr DN
    Lancet; 1972 Sep; 2(7776):537-8. PubMed ID: 4115589
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term effects of cyclophosphamide therapy in treatment of the "primary" nephrotic syndrome of childhood].
    Lama G
    Pediatria (Napoli); 1976 Jun; 84(2):320-30. PubMed ID: 798171
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclophosphamide and malignancy.
    Puri HC; Campbell RA
    Lancet; 1977 Jun; 1(8025):1306. PubMed ID: 68399
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide.
    Cameron JS; Chantler C; Ogg CS; White RH
    Br Med J; 1974 Oct; 4(5935):7-11. PubMed ID: 4425844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term cyclophosphamide in corticosteroid treated childhood nephrosis.
    Sheth KJ; Liu CC; Good TA
    Wis Med J; 1974 May; 73(5):S55-60. PubMed ID: 4830366
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term assessment of cyclophosphamide therapy for nephrosis in children.
    McDonald J; Murphy AV; Arneil GC
    Lancet; 1974 Oct; 2(7887):980-2. PubMed ID: 4138088
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of cyclophosphamide treatment of primary nephrotic syndrome in children].
    Starkiewiczowa J; Fydryk J; Lupa B
    Pediatr Pol; 1975 Jan; 50(1):31-6. PubMed ID: 1110844
    [No Abstract]   [Full Text] [Related]  

  • 10. Alkylating agents in the treatment of nephrotic syndrome.
    West CD
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():199-210. PubMed ID: 4620919
    [No Abstract]   [Full Text] [Related]  

  • 11. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children.
    Lancet; 1974 Aug; 2(7878):423-7. PubMed ID: 4137139
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclophosphamide in the treatment of adult nephrotic syndrome.
    Gulati PD; Rizvi SN; Ajmani SK; Bhasin RC; Vaishnava H
    J Assoc Physicians India; 1973 Jan; 21(1):23-9. PubMed ID: 4792697
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclophosphamide pulse therapy in relapsing nephrotic syndrome.
    Wardle EN
    Nephron; 1991; 58(3):377. PubMed ID: 1896110
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclophosphamide therapy in adults with minimal-change nephrotic syndrome.
    Uldall PR; Feest TG; Morley AR; Tomlinson BE; Kerr DN
    Lancet; 1972 Jun; 1(7763):1250-3. PubMed ID: 4113514
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic myelogenous leukaemia as a possible consequence of immunosuppressive treatment of nephrotic syndrome (author's transl)].
    Cáp J; Misíková Z
    Monatsschr Kinderheilkd (1902); 1975 Oct; 123(10):718-20. PubMed ID: 1058334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide in pregnancy.
    Coates A
    Aust N Z J Obstet Gynaecol; 1970 Feb; 10(1):33-4. PubMed ID: 5269081
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood.
    Barratt TM; Cameron JS; Chantler C; Ogg CS; Soothill JF
    Arch Dis Child; 1973 Apr; 48(4):286-90. PubMed ID: 4574639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide and the nephrotic syndrome.
    Drummond KN
    Br Med J; 1969 May; 2(5656):576-7. PubMed ID: 5769897
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Hyperpigmentation after cancer chemotherapy.
    Lancet; 1975 Jul; 2(7925):128. PubMed ID: 49718
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclophosphamide and sterility.
    Med Lett Drugs Ther; 1973 Jul; 15(15):62-3. PubMed ID: 4712986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.